BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16846484)

  • 1. More on 'universal'versus'selected' screening for thrombophilia: the hidden costs of false-positive diagnosis.
    Favaloro EJ
    Br J Haematol; 2006 Jul; 134(2):239-40; author reply 241. PubMed ID: 16846484
    [No Abstract]   [Full Text] [Related]  

  • 2. Universal or selected screening for thrombophilia.
    Keeling D
    Br J Haematol; 2006 Apr; 133(1):106-7. PubMed ID: 16512838
    [No Abstract]   [Full Text] [Related]  

  • 3. Is screening for thrombophilia cost-effective?
    Wu O; Greer IA
    Curr Opin Hematol; 2007 Sep; 14(5):500-3. PubMed ID: 17934357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for thrombophilia.
    Blickstein D
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):389-95. PubMed ID: 16962916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multicentre randomised clinical trial to evaluate the benefit of testing for thrombophilia following a first venous thromboembolism: the NOSTRADAMUS study].
    Cohn DM; Middeldorp S
    Ned Tijdschr Geneeskd; 2007 Feb; 151(6):371-3. PubMed ID: 17352304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraception and thrombophilia.
    Blickstein D; Blickstein I
    Curr Opin Obstet Gynecol; 2007 Aug; 19(4):370-6. PubMed ID: 17625421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Present status and problems of mass screening--from the viewpoint of public health].
    Miyake K
    Hokkaido Igaku Zasshi; 1986 Jul; 61(4):515-9. PubMed ID: 3093347
    [No Abstract]   [Full Text] [Related]  

  • 8. Low molecular weight heparin for pregnancy complications?
    Greer IA
    Thromb Res; 2009; 123 Suppl 3():S22-5. PubMed ID: 19203642
    [No Abstract]   [Full Text] [Related]  

  • 9. Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective.
    O'Brien SH; Smith KJ
    J Pediatr; 2009 Jul; 155(1):100-4. PubMed ID: 19324372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peutz-Jeghers syndrome and screening for pancreatic cancer.
    Latchford A; Greenhalf W; Vitone LJ; Neoptolemos JP; Lancaster GA; Phillips RK
    Br J Surg; 2006 Dec; 93(12):1446-55. PubMed ID: 17115408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
    Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombophilia and women's health: An overview.
    Blickstein I
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):347-56. PubMed ID: 16962913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early termination of the multicentre randomised clinical trial to evaluate the benefit of testing for thrombophilia following a first venous thromboembolism: the NOSTRADAMUS study].
    Cohn DM; Middeldorp S
    Ned Tijdschr Geneeskd; 2008 Sep; 152(38):2093-4. PubMed ID: 18837187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for breast cancer in India--is it an appropriate strategy?
    Moss S
    J Natl Cancer Inst; 2008 Sep; 100(18):1270-1. PubMed ID: 18780862
    [No Abstract]   [Full Text] [Related]  

  • 15. Who should be tested for thrombophilia?
    Simioni P
    Curr Opin Hematol; 2006 Sep; 13(5):337-43. PubMed ID: 16888438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for sonography in breast cancer screening?
    Villeirs GM
    JBR-BTR; 2007; 90(3):155-8. PubMed ID: 17696079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The necessity of accurate costs.
    Hankins S
    Am J Prev Med; 2009 Sep; 37(3):258-9. PubMed ID: 19666163
    [No Abstract]   [Full Text] [Related]  

  • 18. [Screening for thrombophilia].
    Lammers T; Schambeck CM
    Hamostaseologie; 2008; 28(3):135-40. PubMed ID: 18521491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical issues in the evaluation of screening and early detection modalities.
    Etzioni R
    Urol Oncol; 2008; 26(3):308-15. PubMed ID: 18452826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.